IR-Med Inc.
IRMEOTCHealthcare● Active
$0.01
+$0.00(+0.00%)
Market Cap$540673
P/E Ratio—
52W High$0.1274
52W Low$0.001
IR-Med Inc. (IRME) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
IRME · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2025Report Date: Aug 14, 2025EPS Actual
-$0.01
Revenue
—
Fiscal Period
Q3 FY2025
FY ends December
Report Date
Aug 14, 2025
After Market Close
🔥 7-Quarter EPS Beat Streak
IRME reports quarterly as a OTC-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$-0.11
Rev. $0.17B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$-0.11
Rev. Est.$0.17B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 2, 2026 | -$0.02 | — | — | — | — | — |
| ◌ Q3 FY2026 | Sep 2, 2026 | -$0.02 | — | — | — | — | — |
| ◌ Q1 FY2026 | Feb 25, 2026 | -$0.02 | — | — | — | — | — |
| — Q3 FY2025 | Aug 14, 2025 | — | -$0.01 | — | — | — | — |
| — Q2 FY2025 | May 15, 2025 | — | -$0.01 | — | — | — | — |
| ▲ Q2 FY2025 | Apr 4, 2025 | -$0.02 | -$0.01 | +50.0% | $0.00B | $0.00B | -93.5% |
| — Q4 FY2024 | Nov 14, 2024 | -$0.01 | -$0.01 | +0.0% | — | $0.00B | — |
| — Q3 FY2024 | Aug 13, 2024 | -$0.01 | -$0.01 | +0.0% | — | — | — |
Q3 FY2026
Sep 2, 2026
EPS Actual
—
EPS Est.
-$0.02
EPS Surpr.
—
Revenue
—
Q3 FY2026
Sep 2, 2026
EPS Actual
—
EPS Est.
-$0.02
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 25, 2026
EPS Actual
—
EPS Est.
-$0.02
EPS Surpr.
—
Revenue
—
Q3 FY2025
Aug 14, 2025
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 15, 2025
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
Apr 4, 2025Beat
EPS Actual
-$0.01
EPS Est.
-$0.02
EPS Surpr.
+50.0%
Revenue
$0.00B
Q4 FY2024
Nov 14, 2024
EPS Actual
-$0.01
EPS Est.
-$0.01
EPS Surpr.
+0.0%
Revenue
—
Q3 FY2024
Aug 13, 2024
EPS Actual
-$0.01
EPS Est.
-$0.01
EPS Surpr.
+0.0%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.02 | $-0.02 | $-0.02 | 1 |
| Q3 FY2027 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q2 FY2027 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q1 FY2027 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q4 FY2026 | $-0.02 | $-0.02 | $-0.02 | 1 |
| Q3 FY2026 | $-0.02 | $-0.02 | $-0.02 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q3 FY2025 | Aug 14, 2025 | — | $0.02 | $0.02 | +0.00% |
| — Q2 FY2025 | May 15, 2025 | — | $0.12 | $0.12 | +0.00% |
| ▲ Q2 FY2025 | Apr 4, 2025 | +50.0% | $0.45 | $0.45 | +0.00% |
| ▲ Q4 FY2024 | Nov 14, 2024 | +0.0% | $0.83 | $0.83 | +0.00% |
| ▲ Q3 FY2024 | Aug 13, 2024 | +0.0% | $0.60 | $0.60 | +0.00% |
| ▲ Q2 FY2024 | May 13, 2024 | +6.1% | $0.90 | $0.85 | -5.56% |
| ▲ Q2 FY2024 | Apr 1, 2024 | +0.0% | $1.30 | $1.40 | +7.69% |
| ▲ Q4 FY2023 | Nov 14, 2023 | +0.0% | $1.00 | $1.00 | +0.00% |
Q3 FY2025+0.00%
Report Date
Aug 14, 2025
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.02
Q2 FY2025+0.00%
Report Date
May 15, 2025
EPS Beat/Miss
—
Price Before
$0.12
Price After
$0.12
Q2 FY2025+0.00%
Report Date
Apr 4, 2025
EPS Beat/Miss
+50.0%
Price Before
$0.45
Price After
$0.45
Q4 FY2024+0.00%
Report Date
Nov 14, 2024
EPS Beat/Miss
+0.0%
Price Before
$0.83
Price After
$0.83
Q3 FY2024+0.00%
Report Date
Aug 13, 2024
EPS Beat/Miss
+0.0%
Price Before
$0.60
Price After
$0.60
Q2 FY2024-5.56%
Report Date
May 13, 2024
EPS Beat/Miss
+6.1%
Price Before
$0.90
Price After
$0.85
Q2 FY2024+7.69%
Report Date
Apr 1, 2024
EPS Beat/Miss
+0.0%
Price Before
$1.30
Price After
$1.40
Q4 FY2023+0.00%
Report Date
Nov 14, 2023
EPS Beat/Miss
+0.0%
Price Before
$1.00
Price After
$1.00
Avg Beat Reaction+0.36%
Beat Rate6 / 8 quarters
Largest Move+7.69% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: IRME ends December
IR-Med Inc. (IRME) most recently reported earnings on August 14, 2025 for Q3 FY2025, posting EPS of $-0.01 (in line with the analyst consensus of —). IRME has beaten EPS estimates for 7 consecutive quarters. The next IRME earnings date is expected around September 1, 2026.
Each quarter, investors track IRME earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. IRME revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
IRME's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
IRME earnings · 4 questionsIR-Med Inc.'s next earnings report is expected around September 1, 2026. IRME typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; IRME historically reports after market close (AMC).
IRME earnings datewhen is IRME earningsIRME next earnings datewhen does IRME report earningsIRME earnings calendar
▸ Source: FMP · IR-Med Inc. SEC filings · US GAAP · IR-Med Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026